Resource type: Information leaflet
Publication type: Stroke information
Around 15% of strokes are haemorrhagic (due to bleeding in or around the brain). This guide explains the two different types of stroke caused by a bleed, intracerebral and subarachnoid haemorrhage, and how they are diagnosed and treated.
In a study published in the journal, The Lancet Neurology, scientists analysed data from more than 1,600 adults with cavernoma - a cluster of abnormal blood vessels in the brain - to generate estimates of risk. The findings could help both doctors and patients to make informed decisions about their treatment.
Intracerebral haemorrhage (ICH) is a type of stroke, which is caused by bleeding in the brain, ultimately leading to brain damage, disability and often death. We currently know very little about the biological changes that occur in the brain after intracerebral haemorrhage.
The CROMIS-2 study investigated whether signs of small brain bleeds on routine brain scans can help us understand which ischaemic stroke patients with atrial fibrillation are at increased risk of a bleed in the brain when on anticoagulant ‘blood thinning’ drugs.
Postgraduate fellowship: What is the impact of damaged thinking ability caused by a spontaneous bleed in the brain?
Led by the University of Nottingham, a new international study investigated whether patients with a spontaneous bleed in the brain (intracerebral haemorrhage) could benefit from this drug, if delivered as an emergency treatment. An intracerebral haemorrhage is a type of stroke.
Published online first in the journal Neurology, a new study suggests that people with AF who have an ICH due to their medication have similar outcomes whether they're on a NOAC or a vitamin K antagonist drug.
PRESTIGE-AF is a new multi-million Euro initiative funded by the European Commission has been set up to help prevent stroke in patients with existing conditions.
This study will show whether more intensive lowering of blood pressure (BP) in survivors of intracerebral haemorrhage (ICH) is feasible, safe and effective in reducing brain injury. If successful, the study will pave the way for the design a larger definitive trial.
People with stroke due to brain haemorrhage have swelling around the haemorrhage on their brain scan. More swelling worsens recovery. No treatment improves outcome after this swelling.
The programme will use biological information about cells and molecules, and information from patients, to design a study of treatment for swelling after brain haemorrhage.